HomeCompareRCDTF vs PLD

RCDTF vs PLD: Dividend Comparison 2026

RCDTF yields 2.77% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.45M in total portfolio value
10 years
RCDTF
RCDTF
● Live price
2.77%
Share price
$56.95
Annual div
$1.58
5Y div CAGR
32%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52.6K
Annual income
$9,708.55
Full RCDTF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — RCDTF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCDTFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCDTF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCDTF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCDTF
Annual income on $10K today (after 15% tax)
$235.82/yr
After 10yr DRIP, annual income (after tax)
$8,252.27/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,459,718.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCDTF + PLD for your $10,000?

RCDTF: 50%PLD: 50%
100% PLD50/50100% RCDTF
Portfolio after 10yr
$3.28M
Annual income
$2,633,072.37/yr
Blended yield
80.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

RCDTF
Analyst Ratings
2
Hold
1
Sell
Consensus: Hold
Altman Z
3.4
Piotroski
5/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCDTF buys
0
PLD buys
0
No recent congressional trades found for RCDTF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCDTFPLD
Forward yield2.77%3.18%
Annual dividend / share$1.58$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32%74.4%
Portfolio after 10y$52.6K$6.50M
Annual income after 10y$9,708.55$5,256,436.18
Total dividends collected$28.6K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: RCDTF vs PLD ($10,000, DRIP)

YearRCDTF PortfolioRCDTF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$11,066$366.22$11,255$555.24$189.00PLD
2$12,341$499.95$13,062$1,018.59$721.00PLD
3$13,892$687.80$15,903$1,926.67$2.0KPLD
4$15,820$955.18$20,839$3,823.32$5.0KPLD
5$18,269$1,341.86$30,464$8,166.08$12.2KPLD
6$21,460$1,911.67$52,054$19,457.30$30.6KPLD
7$25,732$2,770.17$109,886$54,188.93$84.2KPLD
8$31,631$4,097.76$304,030$186,451.18$272.4KPLD
9$40,060$6,214.06$1,166,125$840,813.32$1.13MPLD
10$52,572$9,708.55$6,504,190$5,256,436.18$6.45MPLD

RCDTF vs PLD: Complete Analysis 2026

RCDTFStock

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Full RCDTF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this RCDTF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCDTF vs SCHDRCDTF vs JEPIRCDTF vs ORCDTF vs KORCDTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.